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ABSTRACT 
Objective:  The purpose of this study to assess the value of texture analysis (TA) for 
prostate cancer (PCa) detection on T2 weighted images (T2WI) and dynamic contrast-
enhanced images (DCE) by differentiating between the PCa and Benign Prostate 
Hyperplasia (BPH). 
Materials & Methods: This study used 10 retrospective MRI data sets that were 
acquired from men with confirmed PCa. The prostate region of interest (ROI) was 
delineated by an expert on MRI data sets using automated prostate capsule segmentation 
scheme. The statistical significance test was used for feature selection scheme for optimal 
differentiation of PCa from BPH on MR images.  In pre-processing, for T2-WI, Bias 
correction and all images intensities are standardized to a representative template. For 
DCE images, Bias correction and all images are registered to time point 1 for that patient. 
Following pre-processing texture, features from ROI were extracted and analyzed. 
Texture features that were extracted are: Intensity mean and standard deviation, Sobel 
(Edge detection), Haralick features, and Gabor features. 
  vii 
Results: In T2-WI, statistically significant differences were observed in Haralick 
features. In DCE images, statistically significant differences were observed in mean 
intensity, Sobel, Gabor, and Haralick features. 
Conclusion: BPH is better differentiated in DCE images compared to T2-WI. The 
statically significant features may be combined to build a BPH vs. cancer detection 
system in future. 
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Chapter I: Introduction 
In the United States, Prostate cancer (PCa) is the most common non-cutaneous 
malignancy after lung cancer in men with an incident rate of 126 per 100,000 people. The 
American Cancer Society (ACS) reported that the number of new cases of men diagnosed 
with PCa by 2016 will be approximately 180,890 cases. PCa is still considered as the 
second leading cause of cancer death in men. Also, the ACS added that the estimation of 
death will occur from PCa is 26,120 deaths in 2016. Today, research shows that the 
mortality rate is gradually decreasing compared with the past years. This is due to the 
development of prostate cancer screening using serum prostatic specific antigen (PSA) 
and digital rectal examination (DRE), in which early detection of prostate cancer and 
stage identification are possible. However, these traditional evaluations have limitations 
in that they provide inaccurate diagnoses when they are used individually in-patient for 
pre- and post-treatment assessments (Steuber & Huland, 2005; Sved & Gomez, 2004; 
Bock & Klee, 2004). 
The prostate biopsies under trans-rectal ultrasound (TRUS) guidance is a 
following step after an abnormal PSA and DRE. Although TRUS provides 
histopathological examination and identify suspicion lesions, it has low sensitivity and 
provides limited information on the extent and the differentiation of PCa (Shijun Wang, 
2014). Computed Tomography (CT) is also limited in classification of PCa and plays a 
key role only in staging the cancer. 
As a result of these limitations, Magnetic Resonance Imaging (MRI) has emerged 
as a promising solution for excellent noninvasive imaging to detect, localize, and stage 
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the aggressiveness of PCa (Shijun Wang, 2014). However, an MRI provides a somewhat 
accurate prediction of the PCa that has penetrated the prostate capsule and still requires 
an external hardware to strengthen the utility of this imaging modality. Therefore, the 
application of texture analysis (TA) is a promising tool to assess PCa which has an 
advantage in early detection and measurement of the disease without the increase of the 
acquisition time. The goal of this study is to provide an effective tool to achieve an 
oncological control and an accurate preoperative staging of PCa to aid the physicians first 
for an accurate diagnose and the patients for a best treatment decision. 
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Chapter II: Background 
Prostate cancer and treatment options 
In 1853, John Adams, a surgeon at The London Hospital discovered the first 
prostatic cancer case as a rare disease in a 59-year-old male patient by histological 
examination (Li, et al., 2013). One hundred and fifty years later, the number of cases 
diagnosed with prostate cancer has increased remarkably and has become a significant 
health problem in the U.S. with 180,000 new cases and about 31,000 deaths occurring 
annually (Samuel R. Denmeade, 2002). PCa is one of these cancer types that can slowly 
grow, which is not threatening to a patient’s life. Conversely, if the cancer metastasizes, 
the disease will become fatal and there is currently no cure (Bloch, Lenkinski, & Rofsky, 
2008).  
PCa staging relies on three factors: tumor, node, and metastasis (TNM) staging 
(Li, et al., 2013). The tumor cells begin within the prostate gland, and these cells have a 
higher probability of reaching the firm outer edge of the gland, called the capsule, and 
breaking through it, an event called extracapsular extension (ECE) (Feng TS, 2015). 
Compared with organ-confined disease, PCa with ECE is associated with decreased 
overall and cancer-specific survival following radical prostatectomy (Feng TS, 2015).  
 The current treatment options available, such as pelvic lymph node dissection 
(PLND), external beam radiotherapy (EBRT), and radical prostatectomy (RP) have 
significant side effects for patients, such as incontinence, rectal injury, and impotence (Li, 
et al., 2013) (Li, et al., 2013). Since patient’s survival depends on the treatment selection 
that is based on the TNM staging and clinical symptoms, it requires an accurate 
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evaluation using the imaging techniques, which provide a significant contribution to the 
treatment regimen (Shijun Wang, 2014).  MRI is one of the imaging techniques used as a 
determining factor because it is highly sensitive in providing pretreatment information 
and helping the physician in the treatment decision. Furthermore, recent advances in MRI 
with the computer-aided diagnosis (CAD) of the prostate are beginning to meet these 
challenges.  
Clinical staging without imaging: 
Currently, elevated levels of the PSA in the blood and DRE are still used for 
diagnosing and staging prostatic cancer. PSA has been approved by the U.S Food and 
Drug Administration (FDA) in 1986 to be used as a primary biomarker to diagnose PCa 
(Li, et al., 2013). It has some limitation in that it is not capable of differentiating between 
PCa and benign prostatic hyperplasia (BPH). Thus, recent advances in medical imaging, 
such as MRI and other imaging modalities, contribute to the detection of PCa. 
Imaging of prostate cancer 
(PCa): 
Ultrasound Imaging (USI): 
High PSA levels typically 
indicate a blinded sextant TRUS-
guided symmetrical needle biopsy. 
However, TRUS biopsies have 
been associated with a significantly 
lower PCa detection accuracy due Figure (1). Ultrasound Image of the prostate 
indicates the poor sensitivity for PCa detection. 
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to the low specificity of the PSA and poor image resolution of ultrasound. In Figure (1), 
USI has limited spatial resolution and has not proven satisfactory for local staging of 
prostate cancer (American College of Radiology, 2012). Furthermore, prostate cancer 
appears as a hypoechoic lesion in the peripheral zone (PZ) on the transrectal probe. Many 
cancers can be undetected and are presumably isoechoic. In a study of 2427 men 
provided through the American Society, a total of 52 cancers were detected.  Of these, 
TRUS identified 44 (85%), indicating its limited sensitivity. The addition of color and 
power Doppler (PD) has been reported to improve the detection of PCa by identifying 
increased vascularity but has not yet been shown to improve staging accuracy (American 
College of Radiology, 2012).  
Computed Tomography (CT) 
CT lacks sufficient soft tissue contrast in 
initial staging and in assessing the local extent of 
prostatic carcinoma in low-to-intermediate –risk 
patients (Figure 2). However, it has a great value 
in the evaluation of distant spread of the disease 
and should be reserved for use in patients with 
higher probability of metastases (John M. Heath, 
1998).  
Figure (2). CT image of the prostate 
indicates the limitation as it shows 
the low soft tissue contrast in the 
image.  
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Magnetic Resonance Imaging (MRI) 
Magnetic Resonance Imaging has been employed in the development of the 
noninvasive approach to assess and detects PCa because it provides the highest spatial 
resolution compared with the other imaging modalities. It can be performed with or 
without the insertion of the endorectal coil (erCoil) (Figure 4). Although the endorectal 
coil insertion discomfort some patients, using it in 1.5T or higher field strength has the 
benefit of providing the highest spatial resolution among all the imaging modalities. 
Furthermore, the variation of techniques including T1-weighted image (T1-WI), T2 
weighted image (T2-WI), dynamic contrast enhanced image (DCEI), Magnetic 
Resonance spectroscopy (MRS), diffusion weighted image (DWI), provide many 
chanced to diagnose the biologic processes.  
T2 weighted image (T2-WI): 
 T2-WI is the most commonly used since it has led to an excellent image with 
quality and resolution. This is evidenced in the image below, which it shows an 
improvement in the sensitivity of the MRI (Figure 3). Consequently, it is able to detect 
the ECE. Due to the improved sensitivity, MRI is also able to detect the invasion of the 
seminal vesicle (SV) (Abdellaoui, Iyengar & Freeman, 2011). This is because the 
specificity improves from the initial range of between 73% and 80% to a range of 
between 97% and 100%. Therefore, the ECE that has a distance of 0.5 millimeters is 
detected accurately (Abdellaoui, Iyengar & Freeman, 2011).  
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There are intrinsic complexities in imaging prostate that limit staging accuracy. 
The good spatial resolution achieved with the erCoil in 3 Tesla (3T) MRI scan with at 
least halving the voxel size (voxel size 0.35 mm3 v 0.66-1.12 mm3), reveals 
pathoanatomic details on T2-WI not seen at 1.5T or 3T without erCoil, as it shown in 
Figure (4) (Bloch, Lenkinski, & Rofsky, 2008). In T2-WI, the interpretation of PCa can 
be affected by false-positive findings such as prostatitis, post-biopsy hemorrhage, and 
fibrosis. Thus, the addition of functional magnetic resonance imaging (fMRI) is 
necessary to improve the accuracy of diagnosing PCa, such as DCE-MRI, MRS, DWI 
(Li, et al., 2013). 
 
Dynamic Contrast Enhanced MRI (DCE- MRI): 
DCE-MRI can diagnose earlier and more intense enhancement in sites of tumor 
compared with the normal PZ. PCa like any tumors has two factors microvessel density  
(c) Axial Plane T2WI  (d) Coronal Plane T2WI  
* 
* 
Figure (3). Prostate MR images of patient with clinically suspected extracapsular disease. In 
(a), the Axial T2W image of the Base of the Seminal Vesicles.	Note the well-defined thin-
walled Vesicles with homogeneous bright intraluminal signal (fluid). In (b), coronal T2W 
image of the prostate. Note the Yellow arrow is Seminal vesicles; Asterisk is the Urinary 
Bladder; and the Pink arrow is the prostate capsule. 
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(MVD) and angiogenic that were evaluated as prognostic factors in patients with PCa. 
MVD has been correlated with clinical and pathological stage, metastasis, and 
histological grade in PCa (Bloch, Lenkinski, & Rofsky, 2008). Although there is some 
controversy, MVD also has been correlated with disease-specific survival and 
progression after treatment. Moreover, recent data suggest that DCE-MRI can provide 
valuable information about individual MVD in PCa. Thus, there are biological features 
associated with PCa that can be demonstrated with DCE-MRI for further disease 
characterization, as it shown in Figure (5) (Bloch, Lenkinski, & Rofsky, 2008). 
(c) Axial Prostate MRI without erCoil (d) Axial Prostate MRI with erCoil 
Figure (4). Prostate MR images with (a) and without erCoil (b). In (a), the sequence used in 
this image is T2WI with erCoil Note the BPH-nodule in the right central gland (yellow 
arrow), and the nerves and small vessels in the neuro vascular bundle (green arrows). 
(a)Sosna et al., Acad Radiol, Aug 2004 
(b)Bloch et al., Acad Radiol 2004; 11:863-867 
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Magnetic Resonance Spectroscopic Imaging (MRSI): 
The addition of MRSI to MR imaging significantly improves characterization of 
PZ prostate tissue as benign or malignant. Coakley et al. demonstrated that PCa have a 
characteristic loss of the citrate (Cit) peak and gain in the choline/creatine (Cho/Cr) peak 
on MRSI. Moreover, the ratio of Cho to citrate Cit is related to the Gleason score, 
indicating that MRSI provides 
information about tumor aggressiveness 
(American College of Radiology, 2012). 
MRS facilitates the differentiation of 
normal and altered tissue metabolism 
(Figure 6). Therefore, it is different to 
other imaging methods that only assess 
abnormalities of structure or perfusion. 
Incremental improvement in accuracy of 
					Pre-contrast																						 					Early	Post-contrast																						 					Late	Post-contrast																						
Figure (5). DCE-3D MRI of prostate. Note the features of the BPH nodule (yellow 
arrows), the visualization of the prostate capsule and of structures of the neurovascular 
bundle, as well as the superb anatomical information intraglandular. 
Bloch et al., Acad Radiol 2004; 11:863-867 
 
Figure (6). MRS image of the prostate indicates 
the assessment of metabolic information for 
cancer and BPH. The malignant tissue shows 
an elevation of Cho peak and drop of Cit peak. 
Whereas, the normal prostatic tissue shows the 
opposite elevated Cit and dropped in Cho. 
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cancer detection and staging has been reported when MRSI was added to endorectal-MRI 
(erMRI) alone (American College of Radiology, 2012). As an indicator of outcome, 
MRSI has been shown predictive of biochemical recurrence. However, a recent American 
College of Radiology Imaging Network® (ACRIN®) multicenter trial showed no 
incremental benefit of MRSI for localizing prostate cancer over 1.5T erMRI alone 
(American College of Radiology, 2012). MRSI cannot yet be considered to provide 
significant advantages in local staging before treatment (American College of Radiology, 
2012). 
 
Diffusion-weighted imaging (DWI): 
The inclusion of DWI technique to MR prostate imaging gives an additional 
method to improve prostate tumor detection and localization compared to T2-Weighted 
Images alone (American College of Radiology, 2012). It generates tissue contrast 
reflecting water molecular diffusion using apparent diffusion coefficient (ADC) mapping 
(figure 7). MR diffusion has been used commonly for evaluating acute stroke in the brain. 
Recently, it has been suggested that DWI may also play a role in the early detection of 
tumor response to therapy. 
  
Figure (7). MRI of the prostate. (a) Axial 
T2-W FSE image of the mid-third of the 
prostate. Note the large hypointense area 
in the anterior portion of the gland (white 
arrows). (b) ADC map of DWI, Note the 
area with reduced ADC values 
suggesting tumor in the anterior gland 
(white arrows) with ECE (white arrow 
heads). 
Bloch et al, Cancer Biomarkers 4 (2008) 
251–262 
 
(a) T2W
I 
(b) ADC map of DWI 
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MRI Prostate Challenges: 
Although MRI in managing and detecting the PCa is expanding, its exact role is 
not yet defined. The staging of PCa is still challenging, in which there are potential 
indications for prostate MRI that includes surveillance in patients who are known to have 
low-risk PCa, for staging in patients with intermediate and high-risk cancer prior to 
therapy, and for detection of cancer in patients with elevated PSA but negative TRUS 
biopsy (Sajal S. Pokharel, 2015).   
BPH is not a PCa. It is a benign enlargement of the prostate due to an abnormal 
growth of the noncancerous prostate cells. They differ in the way they develop. PCa 
commences in the outer PZ of the prostate and grown outward invading the surrounding 
tissues whereas in BPH the growth in inward toward the prostate’s core and begins in the 
inner area of the prostate called the transition zone (TZ) that is a ring tissue circling and 
tightening the urethra. This explains why BPH produces noticeable symptoms, such as 
affecting the urination while the PCa is often silent disease with no obvious symptoms 
often for years. 
Computer-aided diagnosis (CAD) Analysis for Prostate Cancer: 
As already discussed, MRI for prostate detection and localization is widely used. 
However, the image interpretation is time consuming and requires high level of expertise 
(Shijun Wang, 2014). At least 10 parameters can be extracted from DCE-MRI scans, 
which make it very challenging for the radiologist to evaluate all the parameters and 
interpret the volume and stage of the lesion in prostate MRI (Sung, et al., 2011). CAD is 
a technology that is able to analyze comprehensively all the parameters of DCE-MRI 
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offering a more reliable in the diagnose and the detection of PCa in situations where they 
might be undetectable (Figure 8) (Sung, et al., 2011). CAD software imports the MR 
images, processes them, and generates colorized maps based on how the contrast 
materials flows into and out the prostate. This enhanced visualized images will help the 
radiologist to distinguish between PCa and benign lesions (Schruff, 2016). Using this 
technology will save time working on large data sets accurately and efficiently (Schruff, 
2016).   
 
 
 
 
 
 
 
 
 
Summary and challenges of PCa vs. BPH overlap: 
The prevalence of PCa necessitates a diagnostic procedure that is both sensitive 
and specific. There are different diagnostic procedures at the disposal of physicians. 
Different procedures bring with them different benefits and limitations. Many of the 
treatment options for PCa result in rectal injuries for the patient, incontinence, and 
impotence. This poses a challenge for the detection and treatment of prostate cancer. The 
(a) Axial Plane T2WI  (b) Color-coded DCE-3D image 
Figure (8). T2WI and DCE-3D image based color-coded image. (a) Transverse T2WI of the 
middle third of the prostate. Large cancer area is in the right peripheral zone and adjacent 
central gland (*). Capsule (arrowhead) is clearly distinguishable and well defined. (b) color-
coded DCE-3D image. Capsule (arrow) shows irregularity, in contrast to well-defined capsule 
(arrowhead). It was diagnosed as ECE. 
Bloch, B. N. et al. Radiology 2007;245:176-185 
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use of the MRI has proved valuable in the detection, localization, and the determination 
of the stage aggressiveness of PCa because it is more sensitive that the other procedures 
available. It helps address the challenges highlighted above in addition to provide better 
results when compared to the other approaches. However, it has a limitation in that it is 
less specific compared to conventional methods. Continued research and improvements 
have offered solutions, which show more promise in terms of the improvement of the 
effectiveness of the MRI in the screening, detection, and localization of PCa.  
Texture Analysis (TA): 
The diagnosis of PCa using the MRI is very challenging, especially during the 
separation of benign confounders, such as inflammation, atrophy, prostatic intra-
epithelial neoplasia, BPH, and the PCa. Although there is an increased interest in the role 
of MRI to evaluate PCa aggressiveness, there is still the need for advanced methods of 
image processing and analysis as a next step to overcome current challenges. TA is a 
branch of image processing, which aims to reduce image information by extracting a 
texture description from image (Brian Barry, 2014). This extraction may allow for the 
mathematical and statistical analyses to detect a subtle MRI signal changes among image 
pixels (Brian Barry, 2014). In other words, it determines the relationship between 
adjacent pixels within an image that is not seen and distinguish by human eye (Wibmer 
A1, 2015).  
It describes how often one grey tone, or pixel intensity, will appear in a specified 
spatial relationship to another grey tone on the image (Wibmer A1, 2015; Haralick RM, 
1973). By using a series of mathematical equations, it generates a range of quantitative 
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parameters called “texture features” that characterize the spatial variation of grey levels 
throughout an image (Wibmer A1, 2015). The early changes in the image texture are of 
particular relevance, as relatively normal-appearing tissues with subtle microscopic 
disturbances due to disease, such as in the case of hepatic fibrosis, may be detected in its 
earlier stages (HeiShun Yu, 2015). The major advantage of this approach is the ability to 
detect early and quantify a chronic disease without increasing the acquisition time of the 
image or the dose for the patient.  
TA is commonly done using the MATLAB analysis software. In the first-order 
grey scale analysis, individual pixels are analyzed for their values. The mean values, and 
the difference between the minimal and maximal pixel values is determined. In the 
second order grey scale analysis, the co-occurrence matrices are used to analyze the 
textural features. For instance, entropy matrices determine the extent of the PCa, and the 
distribution of its intensities. Contrast matrices are used in determining the weighted 
mean differences of the neighboring pixels’ intensity. The correlation is used to 
determine the relationship between the intensity of neighboring pixels. Using these 
analyses, analysts can tell benign cells from cancerous cells (Nguyen et al., 2012). 
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Chapter III: Methods and Materials 
Data 
The data cohort of 10 patients in this study was collected from a previously 
conducted retrospective study approved by the Institutional Review Board (IRB) at The 
Beth Israel Deaconess Medical Center (BIDMC). All of these patients in this prospective 
study were confirmed to have PCa through positive core needle biopsy. Before 
performing the radical prostatectomy, they were scanned using 3T MRI scan with both a 
torso-phased array coil and an erCoil. After the surgery, it was ensured that the sectioning 
was done in a plane corresponding to the pre-operative MRI by sectioning and staining 
the excised gland with hematoxylin and eosin [H&E] (Viswanath, et al., 2012).  
McNeal’s recommendation is that patient study was classified into two categories; central 
gland (CG) and PZ PCa if more than 70% of prostate volume was found in a particular 
zone (JE, 1968). From the 22 MRI data sets, 16 were determined as PZ PCa (50 2D 
sections) and 6 were found as having PCa in the CG (30 2D sections). Only those 
sections were chosen to be included in the study, which showed an explicit focus of PCa 
in either CG or PZ to make sure that the sets of CG and PZ PCa were distinct from each 
other (Viswanath, et al., 2012). 
The prostate region of interest (ROI) was delineated by an expert pathologist on 
T2-WI and DCEI using automated prostate capsule segmentation scheme. A total of 110 
texture features were then extracted on a per-voxel basis from all T2-WI and DCEI data 
sets. Then, the statistical significance test was used for feature selection scheme is used to 
find an ensemble of features that will allow for optimal differentiation of PCa from BPH 
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on MRI.   
Pre-processing 
The pre-processing procedures for the T2-WI involved the correction of the bias 
and the standardization of the image intensities to yield a representative image. For the 
DCE images, the pre-processing procedures involved the correction of bias, and the 
registration of images to the point 1 for every patient. Following pre-processing, the 
texture features from ROI were extracted and analyzed. Some of the texture features that 
were extracted included the intensity mean and standard deviation, Sobel (edge 
detection), Haralick features, and Gabor features.  
The intensity mean and the standard deviation are important value in the analysis 
of digital images. This is especially the case when the TA is performed using MATLAB. 
The mean values for the intensity are used in the first order grey scale analysis. The 
standard deviation is an important part of the interpretation of the mean intensity. 
The other texture feature was Sobel (edge detection). The analysis of the data 
required the determination of the intensity of the digital images taken using the MRI 
machine and the DCE-MRI. The intensity function can only be determined at discrete 
points. The underlying assumption in the application of the Sobel operator for edge 
detection is that there is a continuous intensity function. The Sobel operator serves as a 
differentiation operator, which is determined by the approximation of the image intensity 
function’s gradient. 
Haralick features and Gabor features were also some of the texture features. 
Haralick features are important in the differentiation of the homogenous low Signal 
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intensity (SI) regions of the PCa. The analysts use the Haralick features to differentiate 
them from the normal prostate, which have a hyper-intense appearance (Haralick, 1973). 
The Gabor feature of interest was the Gabor wavelet transform. This was acquired 
through the application of the Gaussian function to modulate a complex sinusoid. The 
purpose of this feature is to the matching of localized frequency characteristics based on 
their scales and orientations. This feature is important in the identification of the 
appearance of PCa. This is through the quantification of the visual processing features 
that radiologists rely upon in the examination of the appearance of the PCa. 
 
  
  
18 
Chapter IV: Results 
Figures 9 and 10 show box-and-whisker plots comparing the intensity difference 
between the two data sets; cancer (1) and BPH (2) for T2-WI and DCE images. The 
analysis of the images provides a statistically significant difference in the T2-WI as was 
observed using the Haralick features as it shown in Figure (4).  While in Figure (5), it 
shows that there is a statistically significant difference in the DCEI that were observed in 
mean intensity, Sobel, Gabor, and Haralick features.  
 
 
Figure (9). Box-and-whisker plots comparing the intensity difference for PCa detection in T2W 
images. It observes a statistically-significant difference in Haralick features. 
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The Figures 11 and 12 show there is a visual difference in the expression of 
features when the cancer is compared to the BPH in T2WI and DCE images. For both 
patients (1 and 2), note the improved visual differentiability between cancer and BPH 
regions on textures features images compared with the original intensity image. Thus, we 
conclude that texture analysis is a promising tool to help in diagnose and differentiate 
between PCa and BPH. 
Figure (10). Box-and-whisker plots comparing the intensity difference for PCa detection in DCE 
images. It observes a statistical significant differences in mean intensity, Sobel, Gabor, and 
Haralick features 
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Patient #1 
Patient #2 
1
Figure (11). Representative data set and improved visual differentiability between PCa and PBH 
regions for patient #1 and #2: (d) mapped PCa and BPH on T2W images (outlined in white, 
from the outlined region. Three texture features are used (a), and (b): the probabilistic heat map 
of PCa presence mapped back into the images, each color map are shown confirmed statistical 
difference in T2W images (arrow). 
2
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Patient #1 
Patient #2 
Figure (12). Representative PCa data set and improved visual differentiability between PCa and 
PBH regions for patient #1 and #2: (d) mapped PCa and BPH on DCE images (outlined in white, 
from the outlined region. Three texture features are used (a), (b), and (c): the probabilistic heat 
map of PCa presence mapped back into the images, each color map are shown confirmed 
statistical difference in DCE images (arrow). 
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Chapter V: Conclusion 
The proper treatment of cancer is dependent on its accurate detection, 
characterization of the tumor, and the differentiation of benign cells and from cancerous 
cells. The major finding in our study is that BPH is better differentiated in DCEI 
compared to T2-WI. The goal of this study is to emphasize the use of TA of non-contrast 
and contrast enhanced MR images to improve the detection and characterization of 
obscured ventral gland tumors of prostate and differentiate between BPH nodules and 
PCa. 
TA presents a solution to mitigate some of the challenges that have been 
addressed in the thesis. TA shows great potential in the detection of PCa. The analysis of 
the intensities in the region of interest using superior software, such as MATLAB has 
shown a significant improvement in the detection of cancerous cells.  
 The accurate detection and characterization of cancer cells is important in 
understanding its prognosis. It also helps to improve the patient outcomes through its 
influence in the formulation of individualized treatments. However, the characterization 
of tumors has been challenged by technological challenges. TA offers a reprieve in that 
regard. TA offers potential for the advancement of this area of cancer research and 
treatment. 
 Finally, TA is important in the differentiation of BPH from cancerous cells. The 
application of texture analysis has shown that there is a statistically significant features 
that may be combined to build a BPH vs cancer detection system in the future. In 
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conclusion, this can potentially develop an important quantitative approach for 
characterizing PCa further in future studies.   
 
  
  
24 
Chapter VI: Discussion 
The initial findings of this study are very promising. The statistically significant 
differences between the BPH and the PCa as determined using the MRI and the DCE-
MRI contributes to the body of information on the subject. It also contributes to the 
understanding of the modalities though which the accuracy in the detection of PCa can be 
improved given the limitations in the methods available.  
 The use of a DCE-MRI results in better differentiation of the BPH when 
compared to the T2-WI, which are taken using a magnetic resonance imaging machine. 
As discussed above, the improved differentiation when the DCE-MRI is used is because 
of the heightened sensitivity. The heighted differentiation of the BPH is also because of 
the increase resolution when the DCE-MRI is used in generating the images of the 
subject.  
 When the DCE-MRI was used, the researcher also found that there were 
statistically significant differences in the mean intensity, Sobel, Gabor, and Haralick 
features. This is very significant for future research into the detection, localization and 
the differentiation between the PCa and the BPH. Researchers can combine the 
statistically significant features in mean intensity, Sobel, Gabor, and Haralick to build a 
detection system that can be used not only in the detection and localization, but also in 
the differentiation of PCa and the BPH 
 This can be achieved by using the statistically significant different features as a 
baseline against which images can be compared. However, there is need for refinement of 
the image and their combination in a manner that helps achieve these objectives. Despite 
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the insurmountable challenges, the thesis made significant findings that not only 
contributed to the body of knowledge but also helped generate a potential area for future 
research in the detection and localization of PCa, as well as the differentiation of PCa and 
the BPH. 
 The current study was limited in the fact that the number of patients who were 
enrolled to participate was small. A small sample size has an effect on the validity and 
credibility of the results. It also affects the sampling criteria and by association, the 
generalizability of the results. Future studies require a detailed logistical planning to 
ensure that a sizable sample is acquired for any studies.  
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